FKDNX
Price
$175.38
Change
-$6.93 (-3.80%)
Updated
Dec 18 closing price
GFACX
Price
$64.14
Change
-$8.99 (-12.29%)
Updated
Dec 18 closing price
Ad is loading...

FKDNX vs GFACX

Header iconFKDNX vs GFACX Comparison
Open Charts FKDNX vs GFACXBanner chart's image
Franklin DynaTech A
Price$175.38
Change-$6.93 (-3.80%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$64.14
Change-$8.99 (-12.29%)
VolumeN/A
CapitalizationN/A
FKDNX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FKDNX vs. GFACX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKDNX is a Buy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 313B vs. FKDNX (27.4B). FKDNX (0.00) and GFACX (0.00) have matching dividends . FKDNX was incepted earlier than GFACX: FKDNX (57 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. FKDNX (15.29). GFACX has a lower initial minimum investment than FKDNX: GFACX (250) vs FKDNX (1000). FKDNX annual gain was more profitable for investors over the last year : 36.61 vs. GFACX (34.28). FKDNX return over 5 years is better than : 107.17 vs. GFACX (47.11).
FKDNXGFACXFKDNX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence57 years24 years-
Gain YTD36.32732.964110%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets27.4B313B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year36.6134.28107%
Returns for 3 years21.5214.71146%
Returns for 5 years107.1747.11227%
Returns for 10 years288.9779.77362%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVAC3.40N/A
N/A
Intevac
AMCX9.74-0.02
-0.20%
AMC Networks
LNW89.80-1.37
-1.50%
Light & Wonder
CALX35.49-0.54
-1.50%
CALIX
NAYA0.80-0.02
-2.43%
NAYA Biosciences Inc